S Hawgood, A Ogawa, K Yukitake, M Schlueter, C Brown, T White, D Buckley, D Lesikar and B Benson
Cardiovascular Research Institute, University of California, San Francisco 94143-0130, USA.

We report the activity of recombinant human surfactant apoprotein-C (rSP-C[Cys]2) and various phospholipids in a preterm rabbit model of respiratory distress syndrome (RDS). Mixtures of rSP-C(Cys)2 and certain phospholipids had similar activity (lung compliance and lung pressure-volume behavior) to rabbit surfactant in this model. The activity of rSP-C(Cys)2 was maximal at 1 mol% protein and varied significantly with the phospholipid composition. Chemically synthesized SP-C had similar activity to rSP-C(Cys)2. Deletion of six amino- terminal residues did not affect function. Substitution of cysteines and cysteine6 with adjacent serines (rSP-C[Ser]2) by site-specific mutagenesis minimized aggregation of rSP-C but did not affect activity. Palmitoylation of cysteine5 and cysteine6 in rSP-C (rSP-C[C16]2) did not enhance the activity of rSP-C(Cys)2. We conclude that bacterial expression is a practical source of functional SP-C, and that nonacylated forms of SP-C may be useful adjuvants to phospholipids in the treatment of RDS and possibly other forms of acute lung injury.

This article has been cited by other articles:

				A. Almlen, G. Stichtenoth, B. Linderholm, M. Haegerstrand-Bjorkman, B. Robertson, J. Johansson, and T. Curstedt Surfactant proteins B and C are both necessary for alveolar stability at end expiration in premature rabbits with respiratory distress syndrome J Appl Physiol, April 1, 2008; 104(4): 1101 - 1108. [Abstract] [Full Text] [PDF]

				W. E. Lawson, V. V. Polosukhin, G. T. Stathopoulos, O. Zoia, W. Han, K. B. Lane, B. Li, E. F. Donnelly, G. E. Holburn, K. G. Lewis, et al. Increased and Prolonged Pulmonary Fibrosis in Surfactant Protein C-Deficient Mice Following Intratracheal Bleomycin Am. J. Pathol., November 1, 2005; 167(5): 1267 - 1277. [Abstract] [Full Text] [PDF]

				J. P. Bridges, S. E. Wert, L. M. Nogee, and T. E. Weaver Expression of a Human Surfactant Protein C Mutation Associated with Interstitial Lung Disease Disrupts Lung Development in Transgenic Mice J. Biol. Chem., December 26, 2003; 278(52): 52739 - 52746. [Abstract] [Full Text] [PDF]

				J. Johansson, M. Some, B.-M. Linderholm, A. Almlen, T. Curstedt, and B. Robertson A synthetic surfactant based on a poly-Leu SP-C analog and phospholipids: effects on tidal volumes and lung gas volumes in ventilated immature newborn rabbits J Appl Physiol, November 1, 2003; 95(5): 2055 - 2063. [Abstract] [Full Text] [PDF]

				S. W. Glasser, E. A. Detmer, M. Ikegami, C.-L. Na, M. T. Stahlman, and J. A. Whitsett Pneumonitis and Emphysema in sp-C Gene Targeted Mice J. Biol. Chem., April 11, 2003; 278(16): 14291 - 14298. [Abstract] [Full Text] [PDF]

				M. Ikegami, T. E. Weaver, J. J. Conkright, P. D. Sly, G. F. Ross, J. A. Whitsett, and S. W. Glasser Deficiency of SP-B reveals protective role of SP-C during oxygen lung injury J Appl Physiol, February 1, 2002; 92(2): 519 - 526. [Abstract] [Full Text] [PDF]

				S. W. Glasser, M. S. Burhans, T. R. Korfhagen, C.-L. Na, P. D. Sly, G. F. Ross, M. Ikegami, and J. A. Whitsett Altered stability of pulmonary surfactant in SP-C-deficient mice PNAS, May 3, 2001; (2001) 101500298. [Abstract] [Full Text]

				E. N. Atochina, M. F. Beers, S. T. Scanlon, A. M. Preston, and J. M. Beck P. carinii induces selective alterations in component expression and biophysical activity of lung surfactant Am J Physiol Lung Cell Mol Physiol, March 1, 2000; 278(3): L599 - L609. [Abstract] [Full Text] [PDF]

				R. G. Spragg, R. M. Smith, K. Harris, J. Lewis, D. Hafner, and P. Germann Effect of recombinant SP-C surfactant in a porcine lavage model of acute lung injury J Appl Physiol, February 1, 2000; 88(2): 674 - 681. [Abstract] [Full Text] [PDF]

				J. MICHNA, A. H. JOBE, and M. IKEGAMI Positive End-expiratory Pressure Preserves Surfactant Function in Preterm Lambs Am. J. Respir. Crit. Care Med., August 1, 1999; 160(2): 634 - 639. [Abstract] [Full Text]

				M. Ikegami, A. D. Horowitz, J. A. Whitsett, and A. H. Jobe Clearance of SP-C and recombinant SP-C in vivo and in vitro Am J Physiol Lung Cell Mol Physiol, June 1, 1998; 274(6): L933 - L939. [Abstract] [Full Text] [PDF]

				T. Kobayashi, K. Tashiro, K. Yamamoto, S. Nitta, S. Ohmura, and Y. Suzuki Effects of surfactant proteins SP-B and SP-C on dynamic and static mechanics of immature lungs J Appl Physiol, December 1, 1997; 83(6): 1849 - 1856. [Abstract] [Full Text] [PDF]

				A. J. DAVIS, A. H. JOBE, D. HÄFNER, and M. IKEGAMI Lung Function in Premature Lambs and Rabbits Treated with a Recombinant SP-C Surfactant Am. J. Respir. Crit. Care Med., February 1, 1997; 157(2): 553 - 559. [Abstract] [Full Text]

				J. J. Conkright, J. P. Bridges, C.-L. Na, W. F. Voorhout, B. Trapnell, S. W. Glasser, and T. E. Weaver Secretion of Surfactant Protein C, an Integral Membrane Protein, Requires the N-terminal Propeptide J. Biol. Chem., April 27, 2001; 276(18): 14658 - 14664. [Abstract] [Full Text] [PDF]

				S. W. Glasser, M. S. Burhans, T. R. Korfhagen, C.-L. Na, P. D. Sly, G. F. Ross, M. Ikegami, and J. A. Whitsett Altered stability of pulmonary surfactant in SP-C-deficient mice PNAS, May 22, 2001; 98(11): 6366 - 6371. [Abstract] [Full Text] [PDF]